Skip to main content
. 2020 Jul 15;31(9):2145–2157. doi: 10.1681/ASN.2020040509

Table 2.

Clinical outcomes of hospitalized patients positive for COVID-19 compared with patients negative for COVID-19 and a historical control

Outcomes, n (%) Hospitalization and Positive for COVID-19 (n=3345) Hospitalization and Negative for COVID-19 (n=1265) Risk Ratio(95% CI) Historical control (n=9859) Risk Ratio (95% CI) (positive for COVID-19 versus historical control)
AKI 1903 (56.9) 471 (37.2) 1.5 (1.4 to 1.6) 2479 (25.1) 2.3 (2.2 to 2.4)
AKI stage
 1 942 (49.5)2 285 (60.5) 1830 (73.8)
 2 387 (20.3) 94 (20.0) 369 (14.9)
 3 574 (30.2) 92 (19.5) 280 (11.3)
Need for RRT 164 (4.9) 20 (1.6) 3.1 (2.0 to 4.9) 93 (0.9) 5.2 (4.0 to 6.7)
Type of RRT
 CRRT 52 (31.7) 5 (25) 25 (26.9)
 PIRRT 11 (6.7) 2 (10) 8 (8.6)
 PD 16 (9.8) 0 0
 HD 85 (51.8) 13 (65) 60 (64.5)
Outcomes of the cohort with stage 3 AKI
 AKI stage 3 with renal recovery 243 (42.3) 63 (68.5) 0.6 (0.5 to 0.7) 179 (63.9) 0.7 (0.6 to 0.8)
 AKI stage 3 with in-hospital death 299 (52.1) 18 (19.6) 2.7 (1.8 to 4.1) 55 (19.6) 2.6 (2.1 to 3.4)
 AKI stage 3 with RRT dependence 32 (5.6) 11 (12.0) 0.5 (0.1 to 0.8) 46 (16.4) 0.3 (0.2 to 0.5)
Outcomes in the total cohort hospitalized during the study period
 Mechanical ventilation 624 (18.7) 126 (10.0) 1.9 (1.6 to 2.4) 486 (4.9) 3.8 (3.4 to 4.3)
 ICU 438 (13.1)a 46 (3.6)b 3.6 (2.7 to 4.8) 323 (3.3) 4.0 (3.5 to 4.6)
 In-hospital death 775 (23.2) 92 (7.3) 3.8 (2.6 to 3.9) 229 (2.3) 10.0 (8.6 to 11.5)
 Discharged to NH 492 (14.7) 162 (12.8) 1.2 (1.0 to 1.4) 1436 (14.6) 1.0 (0.9 to 1.1)
 Discharged home 1650 (49.3) 788 (62.3) 0.8 (0.7 to 0.8) 8108 (82.2) 0.6 (0.57 to 0.62)
 Hospital length of stay (d)c 5 (3–9) 3 (1–6) P<0.001 3 (2–6) P<0.001

CRRT, continuous RRT; PIRRT, prolonged intermittent RRT; PD, peritoneal dialysis; HD, hemodialysis; NH, nursing home.

a

Data available for n=3341.

b

Data available for n=1262.

c

For these comparisons, Wilcoxon rank sum testing was used.